Northwind Pharmaceuticals recalls

Northwind Pharmaceuticals has 13 recalls on record with the FDA and USDA, the earliest in 2015 and the latest reported on 24 Sep 2025. 8 are still ongoing. 1 was reported in the last 12 months. The most frequent reason is manufacturing (cgmp) deviations.

Total recalls13since 2015

Last 12 months1reported

Class I00% of total

Ongoing8latest 24 Sep 2025

Recalls per month, last 24 months

click a bar for that month

0Oct '24 0 0 0Jan '25 0 0 0Apr 0 0 0Jul 0 1 0Oct 0 0 0Jan '26 0 0 0Apr 0 0 0Jul 0 0

Severity split

Class I 0 0%Class II 12 92%Class III 1 8%

Why northwind pharmaceuticals is recalled

Product types

Brands

By year

202518%
2023754%
2018431%
201518%

Ongoing northwind pharmaceuticals recalls

8 active

Reported	Class	Recall	Company	Reason	Where
24 Sep 2025Drug	CLASS II	Sulfamethoxazole and Trimethoprim Tablets recalledSulfamethoxazole And Trimethoprim	Northwind Pharmaceuticals	Packaging Defects	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 4mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Tadalafil Tablets, USP 5 mg recalled by Northwind PharmaceuticalsTadalafil	Northwind Pharmaceuticals	Hidden Drug Ingredients	Nationwide
3 May 2023Drug	CLASS II	Doxazosin Tablets, USP, 4mg recalled by Northwind PharmaceuticalsDoxazosin	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Atorvastatin Calcium Tablets, USP, 10 mg recalledAtorvastatin Calcium	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 2mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide

All northwind pharmaceuticals recalls, newest first

13 total

Reported	Class	Recall	Company	Reason	Where
24 Sep 2025Drug	CLASS II	Sulfamethoxazole and Trimethoprim Tablets recalledSulfamethoxazole And Trimethoprim	Northwind Pharmaceuticals	Packaging Defects	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 4mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Tadalafil Tablets, USP 5 mg recalled by Northwind PharmaceuticalsTadalafil	Northwind Pharmaceuticals	Hidden Drug Ingredients	Nationwide
3 May 2023Drug	CLASS II	Doxazosin Tablets, USP, 4mg recalled by Northwind PharmaceuticalsDoxazosin	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Atorvastatin Calcium Tablets, USP, 10 mg recalledAtorvastatin Calcium	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Glimepiride Tablets, USP 2mg recalled by Northwind PharmaceuticalsGlimepiride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	BusPIRone Hydrochloride Tablets USP, 5 mg recalledBuspirone Hydrochloride	Northwind Pharmaceuticals	Manufacturing (CGMP) Deviations	Nationwide
3 May 2023Drug	CLASS II	Tadalafil Tablets, USP 20 mg recalled by Northwind PharmaceuticalsTadalafil	Northwind Pharmaceuticals	Hidden Drug Ingredients	Nationwide
22 Aug 2018Drug	CLASS II	Valsartan, 160 mg recalled by Northwind Pharmaceuticals	Northwind Pharmaceuticals	Potency & Assay	IN
22 Aug 2018Drug	CLASS II	Valsartan, 80mg recalled by Northwind Pharmaceuticals	Northwind Pharmaceuticals	Potency & Assay	IN

About this list

Records come from FDA enforcement reports and USDA FSIS notices, grouped by normalised name. A company operating under several names may appear more than once.